{
    "article_link": "https://doi.org/10.1016/j.cell.2023.07.004",
    "data": [
        {
            "id": "data_1",
            "omics": "Phosphoproteomics",
            "link": "https://proteomicdatacommons.org/data-study/study?studyId=PDC000359",
            "format": "Processed Data",
            "source": "Proteomic Data Commons",
            "public_id": "PDC000359"
        },
        {
            "id": "data_2",
            "omics": "Proteomics",
            "link": "https://proteomicdatacommons.org/data-study/study?studyId=PDC000358",
            "format": "Processed Data",
            "source": "Proteomic Data Commons",
            "public_id": "PDC000358"
        },
        {
            "id": "data_3",
            "omics": "Proteomics",
            "link": "https://proteomicdatacommons.org/data-study/study?studyId=PDC000360",
            "format": "Processed Data",
            "source": "Proteomic Data Commons",
            "public_id": "PDC000360"
        },
        {
            "id": "data_4",
            "omics": "Phosphoproteomics",
            "link": "https://proteomicdatacommons.org/data-study/study?studyId=PDC000357",
            "format": "Processed Data",
            "source": "Proteomic Data Commons",
            "public_id": "PDC000357"
        },
        {
            "id": "data_5",
            "omics": "Proteomics",
            "link": "https://www.dropbox.com/s/7zul3j1vyrxo40c/processed_data.zip?dl=0",
            "format": "zip",
            "source": "Dropbox",
            "public_id": ""
        },
        {
            "id": "data_6",
            "omics": "Genomics",
            "link": "https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs003152.v1.p1",
            "format": "Processed Data",
            "source": "dbGaP",
            "public_id": "phs003152.v1.p1"
        },
        {
            "id": "data_7",
            "omics": "Transcriptomics",
            "link": "https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs003152.v1.p1",
            "format": "Processed Data",
            "source": "dbGaP",
            "public_id": "phs003152.v1.p1"
        },
        {
            "id": "data_8",
            "omics": "Transcriptomics",
            "link": "https://0-www-ncbi-nlm-nih-gov.brum.beds.ac.uk/geo/query/acc.cgi?acc=GSE154600",
            "format": "txt",
            "source": "Gene Expression Omnibus (GEO)",
            "public_id": "GSE154600"
        },
        {
            "id": "data_9",
            "omics": "Proteomics",
            "link": "https://proteomicdatacommons.org/data-study/study?studyId=PDC000362",
            "format": "Processed Data",
            "source": "Proteomic Data Commons",
            "public_id": "PDC000362"
        },
        {
            "id": "data_10",
            "omics": "Transcriptomics/Proteomics",
            "link": "",
            "format": "",
            "source": "Memorial Sloan Kettering (MSK)-IMPACT",
            "public_id": null
        },
        {
            "id": "data_11",
            "omics": "Transcriptomics/Proteomics",
            "link": "https://doi.org/10.1016/j.cell.2023.07.004",
            "format": "Processed Data",
            "source": "CPTAC-2016",
            "public_id": "CPTAC-2016"
        }
    ],
    "analyses": [
        {
            "id": "analysis_1",
            "analysis_name": "64-Protein Signature Standalone Prediction Model (Discovery Cohort)",
            "analysis_data": [
                "data_3",
                "data_6"
            ],
            "label": {
                "treatment_response": [
                    "sensitive",
                    "refractory"
                ]
            }
        },
        {
            "id": "analysis_2",
            "analysis_name": "CNV-RNA-Protein Cascade Analysis",
            "analysis_data": [
                "data_3",
                "data_6",
                "data_7"
            ],
            "label": {
                "treatment_response": [
                    "sensitive",
                    "refractory"
                ]
            }
        },
        {
            "id": "analysis_3",
            "analysis_name": "TP53 Wild-Type and Mutant Activity Analysis",
            "analysis_data": [
                "data_3",
                "data_6",
                "data_7"
            ],
            "label": {
                "treatment_response": [
                    "sensitive",
                    "refractory"
                ],
                "TP53_activity_type": [
                    "WT",
                    "mutant"
                ]
            }
        },
        {
            "id": "analysis_4",
            "analysis_name": "64-Protein Signature Validation in Frozen Cohort (Independent Subset)",
            "analysis_data": [
                "data_9",
                "data_6"
            ],
            "label": {
                "treatment_response": [
                    "sensitive",
                    "refractory"
                ]
            }
        },
        {
            "id": "analysis_5",
            "analysis_name": "64-Protein + Genomic Signature Combined Prediction Model",
            "analysis_data": [
                "data_3",
                "data_6",
                "data_7"
            ],
            "label": {
                "treatment_response": [
                    "sensitive",
                    "refractory"
                ],
                "BRCA1/2_mutation": [
                    "yes",
                    "no"
                ],
                "Chr17-LOH": [
                    "yes",
                    "no"
                ],
                "TP53_activity_type": [
                    "WT",
                    "mutant"
                ]
            }
        },
        {
            "id": "analysis_6",
            "analysis_name": "Pathway-Based Clustering for HGSOC Subtypes",
            "analysis_data": [
                "data_3",
                "data_7"
            ],
            "label": {
                "cluster_id": [
                    "1",
                    "2",
                    "3",
                    "4",
                    "5"
                ]
            }
        },
        {
            "id": "analysis_7",
            "analysis_name": "Proteomic Cluster Validation in CPTAC-2016",
            "analysis_data": [
                "data_11"
            ],
            "label": {
                "treatment_response": [
                    "sensitive",
                    "refractory"
                ]
            }
        },
        {
            "id": "analysis_8",
            "analysis_name": "TGF-β and Alt-EJ Pathway Interaction Analysis",
            "analysis_data": [
                "data_3",
                "data_9"
            ],
            "label": {
                "treatment_response": [
                    "sensitive",
                    "refractory"
                ]
            }
        },
        {
            "id": "analysis_9",
            "analysis_name": "Immune Infiltration Trend Analysis",
            "analysis_data": [
                "data_1",
                "data_3",
                "data_7"
            ],
            "label": {
                "treatment_response": [
                    "sensitive",
                    "refractory"
                ]
            }
        },
        {
            "id": "analysis_10",
            "analysis_name": "Phosphoproteomic Prediction Model",
            "analysis_data": [
                "data_1",
                "data_4"
            ],
            "label": {
                "treatment_response": [
                    "sensitive",
                    "refractory"
                ]
            }
        },
        {
            "id": "analysis_11",
            "analysis_name": "64-Protein Signature Validation in PDX Models",
            "analysis_data": [
                "data_3"
            ],
            "label": {
                "treatment_response": [
                    "sensitive",
                    "refractory"
                ]
            }
        },
        {
            "id": "analysis_12",
            "analysis_name": "MRM-Based Technical Validation of 22-Protein Subset",
            "analysis_data": [
                "data_5"
            ],
            "label": {
                "biospecimen_type": [
                    "FFPE",
                    "frozen"
                ]
            }
        },
        {
            "id": "analysis_13",
            "analysis_name": "Chr17-LOH Validation in MSK-IMPACT",
            "analysis_data": [
                "data_10"
            ],
            "label": {
                "Chr17-LOH": [
                    "yes",
                    "no"
                ],
                "overall_survival_group": [
                    "high",
                    "low"
                ]
            }
        },
        {
            "id": "analysis_14",
            "analysis_name": "TGF-β/Alt-EJ/bAlt Score Validation in CPTAC-2016",
            "analysis_data": [
                "data_11"
            ],
            "label": {
                "treatment_response": [
                    "sensitive",
                    "refractory"
                ]
            }
        },
        {
            "id": "analysis_15",
            "analysis_name": "64-Protein Signature Standalone Validation in FFPE Validation Cohort",
            "analysis_data": [
                "data_2"
            ],
            "label": {
                "treatment_response": [
                    "sensitive",
                    "refractory"
                ]
            }
        },
        {
            "id": "analysis_16",
            "analysis_name": "Genomic Scars (nTAI/wGII) Analysis",
            "analysis_data": [
                "data_6"
            ],
            "label": {
                "treatment_response": [
                    "sensitive",
                    "refractory"
                ]
            }
        },
        {
            "id": "analysis_17",
            "analysis_name": "Chr17-LOH as Standalone Predictor of Chemo-Sensitivity",
            "analysis_data": [
                "data_6"
            ],
            "label": {
                "Chr17-LOH": [
                    "yes",
                    "no"
                ]
            }
        },
        {
            "id": "analysis_18",
            "analysis_name": "TAP1 Protein Abundance Analysis",
            "analysis_data": [
                "data_3",
                "data_6"
            ],
            "label": {
                "treatment_response": [
                    "sensitive",
                    "refractory"
                ]
            }
        },
        {
            "id": "analysis_19",
            "analysis_name": "Multivariate Logistic Regression for Treatment Response",
            "analysis_data": [
                "data_3",
                "data_6",
                "data_7"
            ],
            "label": {
                "treatment_response": [
                    "sensitive",
                    "refractory"
                ],
                "Chr17-LOH": [
                    "yes",
                    "no"
                ],
                "BRCA1/2_mutation": [
                    "yes",
                    "no"
                ],
                "TP53_activity_type": [
                    "WT",
                    "mutant"
                ]
            }
        },
        {
            "id": "analysis_20",
            "analysis_name": "TGF-β/Alt-EJ Pathway Integration with Clusters",
            "analysis_data": [
                "data_3",
                "data_9"
            ],
            "label": {
                "cluster_id": [
                    "1",
                    "2",
                    "3",
                    "4",
                    "5"
                ],
                "treatment_response": [
                    "sensitive",
                    "refractory"
                ]
            }
        },
        {
            "id": "analysis_21",
            "analysis_name": "Immune Infiltration Validation (CD8A, CD7, CD3D)",
            "analysis_data": [
                "data_1",
                "data_3",
                "data_7"
            ],
            "label": {
                "treatment_response": [
                    "sensitive",
                    "refractory"
                ],
                "cluster_id": [
                    "1",
                    "2",
                    "3",
                    "4",
                    "5"
                ]
            }
        },
        {
            "id": "analysis_22",
            "analysis_name": "64-Protein Signature 3-Fold Cross-Validation in FFPE Validation Cohort",
            "analysis_data": [
                "data_2"
            ],
            "label": {
                "treatment_response": [
                    "sensitive",
                    "refractory"
                ]
            }
        },
        {
            "id": "analysis_23",
            "analysis_name": "Phosphoproteomic Signature Validation in FFPE Validation Cohort",
            "analysis_data": [
                "data_2",
                "data_4"
            ],
            "label": {
                "treatment_response": [
                    "sensitive",
                    "refractory"
                ]
            }
        },
        {
            "id": "analysis_24",
            "analysis_name": "MRM-Based Validation of Full 64-Protein Signature",
            "analysis_data": [
                "data_5"
            ],
            "label": {
                "treatment_response": [
                    "sensitive",
                    "refractory"
                ]
            }
        },
        {
            "id": "analysis_25",
            "analysis_name": "Immune Infiltration Deconvolution Analysis",
            "analysis_data": [
                "data_1",
                "data_3",
                "data_7"
            ],
            "label": {
                "treatment_response": [
                    "sensitive",
                    "refractory"
                ]
            }
        }
    ],
    "results": [
        {
            "analysis_id": "analysis_1",
            "metrics": "AUC_discovery",
            "value": "0.83 (95% CI: 0.77–0.90)",
            "features": [
                "64-protein signature",
                "metabolic, hypoxia, NF-kB pathways"
            ]
        },
        {
            "analysis_id": "analysis_1",
            "metrics": "Sensitivity_discovery",
            "value": "0.35 (95% CI: 0.19–0.52)",
            "features": [
                "64-protein signature"
            ]
        },
        {
            "analysis_id": "analysis_1",
            "metrics": "Specificity_threshold",
            "value": "98%",
            "features": [
                "64-protein signature"
            ]
        },
        {
            "analysis_id": "analysis_1",
            "metrics": "Cross-validation_method",
            "value": "5-fold",
            "features": [
                "64-protein signature"
            ]
        },
        {
            "analysis_id": "analysis_4",
            "metrics": "AUC_discovery",
            "value": "0.79 (95% CI: 0.63–0.96)",
            "features": [
                "64-protein signature"
            ]
        },
        {
            "analysis_id": "analysis_4",
            "metrics": "AUC_validation",
            "value": "0.81 (95% CI: 0.61–1.00)",
            "features": [
                "64-protein signature"
            ]
        },
        {
            "analysis_id": "analysis_4",
            "metrics": "Sensitivity_discovery",
            "value": "0.25 (95% CI: 0.08–0.58)",
            "features": [
                "64-protein signature"
            ]
        },
        {
            "analysis_id": "analysis_4",
            "metrics": "Sensitivity_validation",
            "value": "0.43 (95% CI: 0.14–0.86)",
            "features": [
                "64-protein signature"
            ]
        },
        {
            "analysis_id": "analysis_4",
            "metrics": "Specificity",
            "value": "98%",
            "features": [
                "64-protein signature"
            ]
        },
        {
            "analysis_id": "analysis_5",
            "metrics": "AUC_discovery",
            "value": "0.87 (95% CI: 0.79–0.93)",
            "features": [
                "64-protein signature",
                "BRCA1/2 mutation",
                "Chr17-LOH",
                "TP53 activity"
            ]
        },
        {
            "analysis_id": "analysis_5",
            "metrics": "AUC_validation",
            "value": "0.98 (95% CI: 0.93–1.00)",
            "features": [
                "64-protein signature",
                "BRCA1/2 mutation",
                "Chr17-LOH",
                "TP53 activity"
            ]
        },
        {
            "analysis_id": "analysis_2",
            "metrics": "Fold_Difference",
            "value": "0.77–1.29 (proteins), 0.20–10.18 (RNAs)",
            "features": [
                "TGM2",
                "CARMIL1",
                "CCDC167",
                "TPMT",
                "COX7A2",
                "COX6C",
                "BIRC2"
            ]
        },
        {
            "analysis_id": "analysis_2",
            "metrics": "Combined_FDR",
            "value": "< 0.1",
            "features": [
                "424 genes"
            ]
        },
        {
            "analysis_id": "analysis_2",
            "metrics": "Marginal_p-value",
            "value": "< 0.05",
            "features": [
                "CCDC167"
            ]
        },
        {
            "analysis_id": "analysis_2",
            "metrics": "p-value",
            "value": "0.0046",
            "features": [
                "Chr17-LOH"
            ]
        },
        {
            "analysis_id": "analysis_3",
            "metrics": "p-value",
            "value": "0.011",
            "features": [
                "TP53 wild-type activity"
            ]
        },
        {
            "analysis_id": "analysis_3",
            "metrics": "p-value",
            "value": "0.006",
            "features": [
                "TP53 mutant activity"
            ]
        },
        {
            "analysis_id": "analysis_10",
            "metrics": "AUC_discovery",
            "value": "0.78 (95% CI: 0.70–0.86)",
            "features": [
                "89 phosphosites",
                "metabolic, ERK, Fanconi, Hippo, WNT pathways"
            ]
        },
        {
            "analysis_id": "analysis_10",
            "metrics": "AUC_validation",
            "value": "0.76 (95% CI: 0.65–0.87)",
            "features": [
                "89 phosphosites",
                "metabolic, ERK, Fanconi, Hippo, WNT pathways"
            ]
        },
        {
            "analysis_id": "analysis_12",
            "metrics": "AUC",
            "value": "0.76",
            "features": [
                "22-protein subset in MRM assay"
            ]
        },
        {
            "analysis_id": "analysis_13",
            "metrics": "p-value",
            "value": "0.018 (95% CI: 0.004–0.032)",
            "features": [
                "Chr17-LOH in MSK-IMPACT"
            ]
        },
        {
            "analysis_id": "analysis_14",
            "metrics": "p-value",
            "value": "0.027",
            "features": [
                "Metabolic pathway upregulation in cluster 3",
                "OXPHOS, FAO"
            ]
        },
        {
            "analysis_id": "analysis_14",
            "metrics": "p-value",
            "value": "0.015",
            "features": [
                "Immune infiltration in cluster 5"
            ]
        },
        {
            "analysis_id": "analysis_15",
            "metrics": "AUC_validation",
            "value": "0.91 (95% CI: 0.84–1.00)",
            "features": [
                "64-protein signature"
            ]
        },
        {
            "analysis_id": "analysis_16",
            "metrics": "p-value",
            "value": "0.017 (95% CI: 0.003–0.031)",
            "features": [
                "nTAI in sensitive tumors"
            ]
        },
        {
            "analysis_id": "analysis_16",
            "metrics": "p-value",
            "value": "0.053 (95% CI: 0.032–0.074)",
            "features": [
                "wGII in sensitive tumors"
            ]
        },
        {
            "analysis_id": "analysis_17",
            "metrics": "p-value",
            "value": "0.0046",
            "features": [
                "Chr17-LOH association with sensitivity"
            ]
        },
        {
            "analysis_id": "analysis_18",
            "metrics": "p-value",
            "value": "0.011",
            "features": [
                "TAP1 protein abundance"
            ]
        },
        {
            "analysis_id": "analysis_19",
            "metrics": "Odds_Ratio",
            "value": "15.76 (Chr17-LOH), 4.75 (BRCA1/2 mutation), 0.4 (loss of WT TP53 activity)",
            "features": [
                "Chr17-LOH",
                "BRCA1/2 mutation",
                "TP53 activity"
            ]
        },
        {
            "analysis_id": "analysis_20",
            "metrics": "p-value",
            "value": "0.038 (95% CI: 0.012–0.064)",
            "features": [
                "TGF-β score in cluster 4 refractory tumors"
            ]
        },
        {
            "analysis_id": "analysis_20",
            "metrics": "p-value",
            "value": "0.029 (95% CI: 0.008–0.050)",
            "features": [
                "bAlt score in cluster 4 refractory tumors"
            ]
        },
        {
            "analysis_id": "analysis_21",
            "metrics": "p-value",
            "value": "0.015 (95% CI: 0.004–0.026)",
            "features": [
                "CD8A, CD7, CD3D as immune markers in cluster 5 refractory tumors"
            ]
        },
        {
            "analysis_id": "analysis_22",
            "metrics": "AUC_validation",
            "value": "0.91 (3-fold CV, 95% CI: 0.84–1.00)",
            "features": [
                "64-protein signature"
            ]
        },
        {
            "analysis_id": "analysis_23",
            "metrics": "AUC_validation",
            "value": "0.76 (95% CI: 0.65–0.87)",
            "features": [
                "89 phosphosites",
                "metabolic, ERK, Fanconi, Hippo, WNT pathways"
            ]
        },
        {
            "analysis_id": "analysis_24",
            "metrics": "AUC_validation",
            "value": "0.76",
            "features": [
                "22-protein subset in MRM assay"
            ]
        },
        {
            "analysis_id": "analysis_25",
            "metrics": "Pearson_correlation",
            "value": "High correlation with pathologist-reviewed cell types",
            "features": [
                "Immune infiltration markers",
                "stromal/epithelial proportions"
            ]
        }
    ]
}